Oncology/Hematology Archives

On-Demand Webinar

RAPS Sponsored Webcast: Optimizing Pediatric Oncology Drug Development: A Comprehensive Overview

Developing safe and effective oncology medications for children presents unique challenges due to ethical considerations…

CertaraOctober 17, 2024

On-Demand Webinar

Quantitative Systems Pharmacology (QSP) Enabled First-in-Human Study in Oncology

CertaraSeptember 16, 2024

On-Demand Webinar

Using Quantitative Systems Pharmacology (QSP) Modeling for Oncology Dose Optimization

The FDA’s Project Optimus initiative aims to reform dose optimization and selection for oncology therapies…

CertaraAugust 19, 2024

Case Study

Model-Informed Confidence in Oncology Dose Selection

Discover an oncology-focused company that gained confidence in their dose selection for an AML trial…

CertaraAugust 9, 2024

Video

Certara’s MIDD Oncology Capabilities

Improve Oncology Study Decisions with Certara's MIDD Team Transcript: The pace of oncology drug…

CertaraAugust 7, 2024

Publication

Dosing Strategies and Quantitative Clinical Pharmacology for Bispecific T-Cell Engagers Development in Oncology

CertaraJuly 23, 2024

Press Coverage

Accelerating the Progress of Kinase Inhibitors in Oncology

The potential of PBPK modeling in answering key questions around these drugs. Hannah Jones, PhDMasoud…

CertaraMay 20, 2024

Publication

Incorporating Pragmatic Elements in Study Designs to Enhance Oncology Randomized Clinical Trials

A FRIENDS OF CANCER RESEARCH WHITE PAPER The article explores the complex landscape of determining…

CertaraDecember 19, 2023

Poster

FDA Trends for Accelerated Drug Approvals in Oncology Indications

The FDA has modified and increased expectations around data needed to support accelerated approvals in…

CertaraSeptember 20, 2023

Poster

Adoption of PROs in Early Clinical Trials for Oncology Drugs: Challenges and Opportunities

Despite changes in regulatory expectations, adoption of PROs in early-phase oncology trials remains very low…

CertaraSeptember 20, 2023

Oncology/Hematology

RAPS Sponsored Webcast: Optimizing Pediatric Oncology Drug Development: A Comprehensive Overview

Quantitative Systems Pharmacology (QSP) Enabled First-in-Human Study in Oncology

Using Quantitative Systems Pharmacology (QSP) Modeling for Oncology Dose Optimization

Model-Informed Confidence in Oncology Dose Selection

Certara’s MIDD Oncology Capabilities

Dosing Strategies and Quantitative Clinical Pharmacology for Bispecific T-Cell Engagers Development in Oncology

Accelerating the Progress of Kinase Inhibitors in Oncology

Incorporating Pragmatic Elements in Study Designs to Enhance Oncology Randomized Clinical Trials

FDA Trends for Accelerated Drug Approvals in Oncology Indications

Adoption of PROs in Early Clinical Trials for Oncology Drugs: Challenges and Opportunities

Newsletter sign up

Quick links

Solutions

Contact